Literature DB >> 7135195

The demonstration and significance of neural compression after spinal injury.

R K Jelsma, J F Rice, L F Jelsma, P T Kirsch.   

Abstract

Standard metrizamide myeLography and CT myelography can accurately and safely define neural compression after a spinal injury. A lateral C1-C2 spinal puncture and a radiolucent fracture board reduce movement of the spine, and by injecting metrizamide in an isotonic concentration and by limiting the amount of contrast above a block, the risk of seizure is minimized. This capability for directly determining neural compression has important implications for the treatment of spinal fractures, and the significance of persisting posttraumatic neural compression is discussed. We believe neural compression should be the primary indication for surgical decompression after spinal injury and that evaluation for it should now be a standard part of the examination of patients with spinal fractures with potential for neurological recovery.

Entities:  

Mesh:

Year:  1982        PMID: 7135195     DOI: 10.1016/0090-3019(82)90357-3

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  5 in total

1.  Neurological outcome after surgery for thoracic and lumbar spine injuries.

Authors:  J Wiberg; H N Hauge
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

2.  Post-traumatic spinal stenosis.

Authors:  G M Weisz
Journal:  Arch Orthop Trauma Surg       Date:  1986

3.  Analysis of 75 operated thoracolumbar fractures and fracture dislocations with and without neurological deficit.

Authors:  M Aebi; J Mohler; G Zäch; E Morscher
Journal:  Arch Orthop Trauma Surg       Date:  1986

4.  The value of more aggressive management in traumatic paraplegia.

Authors:  R Braakman
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

5.  MR-imaging of chronic spinal cord injury. Association with neurologic function.

Authors:  A Nidecker; M Kocher; M Maeder; O Gratzl; G A Zäch; U F Benz; B Burckhardt
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.